Stay updated on Daratumumab in Renal-Impaired Myeloma: Efficacy Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in Renal-Impaired Myeloma: Efficacy Clinical Trial page.

Latest updates to the Daratumumab in Renal-Impaired Myeloma: Efficacy Clinical Trial page
- Check7 days agoChange DetectedAdded a Locations section with Attica as a study site and updated the page revision to v3.3.3.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedPublications section wording was updated to clarify automatic population from PubMed (and related notifications), and the revision label changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedNotice informs users of possible data delays due to a lapse in government funding. It directs readers to cc.nih.gov and opm.gov for current operating status and notes that the NIH Clinical Center is open.SummaryDifference0.4%

- Check57 days agoChange DetectedNo additions or deletions were observed between the old and new screenshots; the page content appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check86 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference3%

- Check93 days agoChange DetectedReplace 'Plasma cell myeloma' with 'Multiple myeloma' and update version to v3.1.0 while removing v3.0.2.SummaryDifference0.2%

Stay in the know with updates to Daratumumab in Renal-Impaired Myeloma: Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in Renal-Impaired Myeloma: Efficacy Clinical Trial page.